- Q1 2024 Indorama Ventures PCL Earnings Presentation (Pre-recorded) TranscriptMay 13, 2024
- Q3 2023 Indorama Ventures PCL Earnings Presentation (Pre-recorded) TranscriptNov 16, 2023
- Q2 2023 Indorama Ventures PCL Earnings Presentation (Pre-recorded) TranscriptAug 16, 2023
- Indorama Ventures PCL IOD Day TranscriptJul 19, 2023
- Q1 2023 Indorama Ventures PCL Earnings Presentation (Pre-recorded) TranscriptMay 10, 2023
- Indorama Ventures PCL Capital Markets Day TranscriptMar 01, 2023
- Q4 2022 Indorama Ventures PCL Earnings Presentation (Pre-recorded) TranscriptFeb 27, 2023
- Q3 2022 Indorama Ventures PCL Earnings Presentation TranscriptNov 14, 2022
- Q2 2022 Indorama Ventures PCL Earnings Presentation TranscriptAug 11, 2022
- Q1 2022 Indorama Ventures PCL Earnings Presentation TranscriptMay 12, 2022
- Q4 2021 Indorama Ventures PCL Earnings Call TranscriptFeb 28, 2022$13.99Earnings
- Indorama Ventures PCL Capital Market's Day TranscriptFeb 11, 2022
- Q3 2021 Indorama Ventures PCL Earnings Call TranscriptNov 06, 2021Earnings
- Ultrapar Participacoes SA Signs Agreement To Sell Oxiteno To Indorama Ventures PCL - M&A Call TranscriptAug 16, 2021
- Q2 2021 Indorama Ventures PCL Earnings Call TranscriptAug 06, 2021$11.88 (+1.67%)Earnings
- Q1 2021 Indorama Ventures PCL Earnings Call TranscriptMay 06, 2021$12.95Earnings
- Q4 2020 Indorama Ventures PCL Earnings Call TranscriptFeb 25, 2021$12.25Earnings
- Q3 2020 Indorama Ventures PCL Earnings Call TranscriptNov 09, 2020$8.1Earnings
- IHS Markit Ltd Chemical Executive Conversations with Indorama Ventures and SABIC TranscriptAug 20, 2020
- Q2 2020 Indorama Ventures PCL Earnings Call TranscriptAug 14, 2020$7.54Earnings
- Q1 2020 Indorama Ventures PCL Earnings Call TranscriptMay 12, 2020$5.36Earnings
- Q4 2019 Indorama Ventures PCL Earnings Call TranscriptFeb 26, 2020$8.48Earnings
- Indorama Ventures PCL Capital Markets Day 2020 TranscriptFeb 04, 2020
- Q3 2019 Indorama Ventures PCL Earnings Presentation TranscriptNov 11, 2019
- Huntsman Corp to Sell its Chemical Intermediates and Surfactants Businesses to Indorama TranscriptAug 08, 2019
- Q2 2019 Indorama Ventures PCL Earnings Presentation TranscriptAug 08, 2019
- Q1 2019 Indorama Ventures PCL Earnings Presentation TranscriptMay 07, 2019
- Q4 2018 Indorama Ventures PCL Analyst Meeting and Capital Markets Day TranscriptFeb 27, 2019
Q2 2021 Indorama Ventures PCL Earnings Call Transcript
Well, I'd like to welcome our viewers here today. Indorama Ventures, or IVL, this morning reported its second quarter earnings update, and they reported a core EBITDA of USD 477 million. Today, I'm joined by IVL's CEO, Mr. D.K. Agarwal. Welcome, sir, and please tell us what's driving this result.
So thank you, Stuart, for having me on the spin. You are right, we reported core EBITDA of $477 million, which is a growth of 30% quarter-on-quarter. This is testimony of our business model, of business resiliency, geographical diversification and product diversification. The demand in the entire value chain has been quite strong in spite of interruption in the supply chain.
The PET has come out as a very preferred polymer. And as the stimulus packages came up, the consumer demand is stronger. But when we look at Lifestyle, we look at Mobility, Hygiene or on the Oxide side. Of course, the Olympus program is also on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)